RT @cardiomet_CE: 7) Having established that mineralocorticoid excess causes kidney/heart damage, it is plausible to ask whether mineraloco…
7) Having established that mineralocorticoid excess causes kidney/heart damage, it is plausible to ask whether mineralocorticoid action underline the progression of #CKD in #T2D due to variable mechanisms summarized in the 2019 Cochrane #meta_analysis: 🔓 h
7) Having established that mineralocorticoid excess causes kidney/heart damage, it is plausible to ask whether mineralocorticoid action underline the progression of #CKD in #T2D due to variable mechanisms summarized in the 2019 Cochrane #meta_analysis: 🔓 h
@BVidalPimentel @thecurbsiders This question is not answered by large definitive trials. The heart failure trials, which added spiro (or eplerenone) to ACEi/ARB, did not find an improvement in eGFR. https://t.co/rPWH0EXOgh https://t.co/1FGLxCgnOv https:/